Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

TDQS

A5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond annotations (readOnly, openWorld, idempotent), the description discloses specific behavioral traits: pulls from SEC EDGAR/XBRL for companies, handles off-calendar fiscal years, sorts results by primary metric, returns citation URIs, and replaces 8-15 sequential lookups. This adds substantial context beyond the annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense but well-structured: starts with trigger phrases, then core function, data source specifics, sorting, and efficiency benefit. Every sentence serves a purpose, with no filler, and is appropriately sized for the tool's complexity.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

The description covers all relevant aspects for a comparison tool: input constraints (2-5), data sources, fiscal year handling, sorting, output (paired data + citation URIs), and performance benefit. With no output schema, it adequately explains return values, making the tool fully understood.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Although schema coverage is 100%, the description enriches parameter meaning: it explains that 'type' determines data source (SEC vs FAERS) and that 'values' are tickers/CIKs or drug names with examples. It also clarifies sorting behavior and output structure, adding value beyond the bare schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool performs side-by-side comparison of 2-5 companies or drugs in a single parallel call, with specific trigger phrases. It distinguishes itself from siblings like entity_profile (single entity) and resolve_entity by explicitly preferring this over sequential single-pack lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly instructs 'ALWAYS PREFER over sequential single-pack lookups when comparing entities', providing clear when-to-use guidance. It also details what each type (company/drug) does, making the decision between entity types obvious.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

Multiple tools have overlapping purposes: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are nearly identical, and deep_research also overlaps with them. The Polymarket tools (polymarket_arbitrage, polymarket_edges, polymarket_edge_tracker, polymarket_fill_risk, polymarket_kalshi_spread) also have fuzzy boundaries. An agent could easily pick the wrong meta-tool or duplicate functionality.

Naming Consistency3/5

All names are snake_case, but the pattern is mixed: some are verb_noun (get_item, list_subscriptions, resolve_entity), some are noun_noun (entity_profile, pipeworx_feedback, polymarket_edges), some are adjective_noun (deep_research, recent_alerts), and a few are single verbs (forget, recall, remember, subscribe). This is readable but not a consistent convention.

Tool Count2/5

With 36 tools, this is far too many for a server named 'hackernews'. The bulk of the tools concern Pipeworx data research, prediction markets, memory, and subscriptions — unrelated to the server's apparent purpose. Many of these could be split into separate servers, and the HN-specific functionality would be better served by a focused set of ~5-8 tools.

Completeness2/5

For the Hacker News domain implied by the server name, the surface is incomplete: there are read-only tools (search, top stories, item/comments) but no write functionality (submit, comment, vote) and no user profile access. The broader data-research capabilities are fairly comprehensive, but that does not rescue the server's coherence given its stated name.